AzTrials
AzTrials

Postoperative PainEarly Phase 1NCT00819962

Perioperative Analgesia Using Ultrasound (US) Guided Transversus Abdominis Plane (TAP) Block

A Early Phase 1 study testing Bupivacaine and TAP in people with Postoperative Pain, run by King Saud University at 2 sites in Saudi Arabia.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Perioperative analgesia using US guided TAP block Read more about this study

Who is it for?
Ages 20 to 50 years
Conditions the study is for
Postoperative Pain
What is being tested?
Bupivacaine and TAP
Could I receive a placebo?
No, everyone receives an active treatment
How many people
42 participants
Where
2 sitesSaudi Arabia
Study dates
Sep 2014to Dec 2016
Phase
Early Phase 1
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 50 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • adult undergoing laparoscopic cholecystectomy

Who cannot join

  • history of cardiorespiratory disease

Trial locations and contacts

2 sites in 1 country.

abdelazeem a dawlat, md contact

4692007

dawlatly@ksu.edu.sa

Saudi Arabia2 sites, 2 recruiting
  • A Dawlatly

    Riyadh, Riyadh Region

    a dawlatly a abdelaz, 00966 503261042, dawlatly@ksu.edu.sa

    a a daw, md

    Recruiting
  • A Dawlatly

    Riyadh, Riyadh Region

    a dawlatly a abdelaz

    a a daw, md

    Recruiting

Other trials in Saudi Arabia

About this study

Perioperative analgesia using US guided TAP block

Read the detailed description

Perioperative analgesia using US guided TAP block

Being tested
Bupivacaine, TAP
Medical subject headings
Pain, Postoperative

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT00819962
Study groupRoleWhat they receive
TAPOtherksu
Receives: Drug: Bupivacaine; Other: TAP

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Pain relief

    Measured: after US TAP block

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Jan 2009 (estimated)
  2. Study startSep 2014
  3. Primary completionDec 2015 (estimated)
  4. Study completionDec 2016 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Early Phase 1
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Crossover
Masking
Double blind
Who is masked
Participant, Investigator
Enrolment
42 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00819962
Sponsor's protocol ID
08-652
Status last verified
Nov 2014
First submitted
6 Jan 2009
Last updated
15 Sep 2015
Results posted
No
Data monitoring committee
Yes

Questions about this trial

What is this clinical trial studying?

A Early Phase 1 study testing Bupivacaine and TAP in people with Postoperative Pain, run by King Saud University at 2 sites in Saudi Arabia.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 15 Sep 2015. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Saudi Arabia. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Early Phase 1 (sometimes called Phase 0) studies give a very small amount of a treatment to a few people, mainly to see how the body handles it.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact abdelazeem a dawlat, md (4692007, dawlatly@ksu.edu.sa), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Pain relief (time frame: after US TAP block). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Sep 2015.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in